The 2016 Priceline Pharmacy Kooyong Classic saw a health check by a pharmacist or on a digital health kiosk happening every three minutes. The event, which wrapped up recently, saw …

A Minor Ailments Scheme similar to that in the UK or Canada would be an evidence-based program aimed at improving the health of Australians, industry stakeholders say. On Monday prominent …

Business confidence has jumped to levels not seen since 2011, and the health and community services sector is most confident of all, according to new Sensis data. The latest Sensis …

GPs are significantly overestimating the proportion of elderly patients they vaccinate against pneumococcal pneumonia, new research has found. The findings reveal one in four GPs report vaccinating at least 75% …

Churn chi Koay (pictured center) has won the Australian Medicines Handbook’s pre-publication prize, comprising of flights, accommodation, conference registration and meal vouchers for up to 2 people to attend an …

The proposed Minor Ailments Scheme based in pharmacy is just “a push by the pharmaceutical industry and pharmacy business to increase drug sales under the guise of health innovation,” according …

The Government’s desire to control community pharmacy is starting to look dangerously Soviet, writes Peter Feros The Soviet era is long gone, but its spirit felt alive and well as …

A new study has revealed traditional Chinese acupuncture treatments are no better than fake acupuncture for treating menopause symptoms – but both may produce a desired result. In a surprise …

With between 31% and 58% of Australians found to suffer from vitamin D deficiency, Carl Gibson, chief executive of Complementary Medicines Australia, has welcomed a new article published in MJA …

Five million Australians pay for a doctor’s visit in an average four week period—but an increasing proportion of them are also going online to look up health and medical information …

Images of empty supermarket shelves and angry parents unable to buy baby formula for their children highlight the impact of a trading practice that needs to be better regulated in …

The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …